Results 231 to 240 of about 553,624 (295)

How the HTAR will contribute to a value‐based decision‐making for medicinal products across the EU

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
The European Union Health Technology Regulation 2021/2282 (HTAR) introduces joint assessment of health technologies (including medicinal products and medical devices) across EU Member States. It was signed into law in 2021 and came into full force in January 2025.
Roisin Adams, Michal Stanak
wiley   +1 more source

Bilateral Ovarian Cystadenoma in a Dog: Morphological and Histopathological Features. [PDF]

open access: yesCase Rep Vet Med
Nozari Z   +4 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Ovarian neoplasms and pregnancy

International Journal of Gynecological Cancer, 2005
The aim of our study was to investigate the incidence of ovarian malignant neoplasms in pregnancy. In the prospective study, during a 2-year period of time, we had the ethical dilemma concerning the conciliar treatment vs the patient's wish to deliver and save the reproductive capabilities. We examined 37 pregnant women; the incidence of ovarian cancer
S, Rakic   +2 more
openaire   +2 more sources

Ovarian Neoplasms in Children

Archives of Surgery, 1993
To review the clinical presentation, treatment, and outcome in a series of children with ovarian neoplasms.A retrospective review of the medical records in a case series of 29 girls with ovarian neoplasms. The length of follow-up ranged from 6 months to 7 1/2 years and averaged 3.0 years in the girls with malignant tumors.The patients were treated at a
M A, Skinner   +3 more
openaire   +2 more sources

Ovarian neoplasms of childhood

Pediatric Radiology, 2019
Ovarian neoplasms are rare in children. Although usually asymptomatic, they sometimes present with abdominal pain, abdominal distension or palpable mass. The distribution of neoplasms in the pediatric population is different from in adults; benign mature cystic teratoma is the most common ovarian tumor in children.
Shailee V. Lala, Naomi Strubel
openaire   +2 more sources

Management of Borderline Ovarian Neoplasms

Journal of Clinical Oncology, 2007
Over the last decades, the management of borderline ovarian tumors (BOTs) has changed from radical surgery to more conservative therapy as a result of the need for fertility-sparing surgery and the increasing use of laparoscopy. The question is whether this is good clinical practice from an oncologic point of view.
Cadron, Isabelle   +5 more
openaire   +3 more sources

Ovarian Neoplasms in a Hermaphrodite

New England Journal of Medicine, 1949
HERMAPHRODITISM in itself is a rare anomaly. The additional occurrence of bilateral gonadal neoplasms is exceedingly uncommon. The present paper reports the case of a "male" hermaphrodite with a pseudomucinous cystadenoma of the right ovary and a dysgerminoma (seminoma) of the opposite gonad.
openaire   +2 more sources

Home - About - Disclaimer - Privacy